Literature DB >> 23851444

Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance.

Shuping Li1, Miaofen G Hu, Yeqing Sun, Norie Yoshioka, Soichiro Ibaragi, Jinghao Sheng, Guangjie Sun, Koji Kishimoto, Guo-Fu Hu.   

Abstract

UNLABELLED: The androgen receptor (AR) is a critical effector of prostate cancer development and progression. Androgen-dependent prostate cancer is reliant on the function of AR for growth and progression. Most castration-resistant prostate cancer (CRPC) remains dependent on AR signaling for survival and growth. Ribosomal RNA (rRNA) is essential for both androgen-dependent and castration-resistant growth of prostate cancer cells. During androgen-dependent growth of prostate cells, androgen-AR signaling leads to the accumulation of rRNA. However, the mechanism by which AR regulates rRNA transcription is unknown. Here, investigation revealed that angiogenin (ANG), a member of the secreted ribonuclease superfamily, is upregulated in prostate cancer and mediates androgen-stimulated rRNA transcription in prostate cancer cells. Upon androgen stimulation, ANG undergoes nuclear translocation in androgen-dependent prostate cancer cells, where it binds to the rDNA promoter and stimulates rRNA transcription. ANG antagonists inhibit androgen-induced rRNA transcription and cell proliferation in androgen-dependent prostate cancer cells. Interestingly, ANG also mediates androgen-independent rRNA transcription through a mechanism that involves its constitutive nuclear translocation in androgen-insensitive prostate cancer cells, resulting in a constant rRNA overproduction and thereby stimulating cell proliferation. Critically, ANG overexpression in androgen-dependent prostate cancer cells enables castration-resistant growth of otherwise androgen-dependent cells. Thus, ANG-stimulated rRNA transcription is not only an essential component for androgen-dependent growth of prostate cancer but also contributes to the transition of prostate cancer from androgen-dependent to castration-resistant growth status. IMPLICATIONS: The ability of angiogenin to regulate rRNA transcription and prostate cancer growth makes it a viable target for therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23851444      PMCID: PMC3800479          DOI: 10.1158/1541-7786.MCR-13-0072

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  45 in total

1.  Combinations for cancer prevention.

Authors:  R A Gupta; R N DuBois
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

2.  Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo.

Authors:  Ulrika W Nilsson; Annelie Abrahamsson; Charlotta Dabrosin
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

3.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

5.  Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA.

Authors:  G f Hu; C j Xu; J F Riordan
Journal:  J Cell Biochem       Date:  2000-01       Impact factor: 4.429

Review 6.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

7.  Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin.

Authors:  K A Olson; H R Byers; M E Key; J W Fett
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

Review 8.  Targeting the androgen receptor pathway in prostate cancer.

Authors:  Yu Chen; Charles L Sawyers; Howard I Scher
Journal:  Curr Opin Pharmacol       Date:  2008-08-12       Impact factor: 5.547

9.  Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Authors:  Soichiro Ibaragi; Norie Yoshioka; Shuping Li; Miaofen G Hu; Saori Hirukawa; Peter M Sadow; Guo-Fu Hu
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

10.  Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.

Authors:  Ulrika W Nilsson Åberg; Niina Saarinen; Annelie Abrahamsson; Tarja Nurmi; Sofia Engblom; Charlotta Dabrosin
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

View more
  15 in total

1.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

2.  Rodent models of osteoporosis.

Authors:  Antonia Sophocleous; Aymen I Idris
Journal:  Bonekey Rep       Date:  2014-12-10

Review 3.  RNA biology of angiogenin: Current state and perspectives.

Authors:  Shawn M Lyons; Marta M Fay; Yasutoshi Akiyama; Paul J Anderson; Pavel Ivanov
Journal:  RNA Biol       Date:  2017-02       Impact factor: 4.652

4.  Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival.

Authors:  Athina Kladi-Skandali; Konstantinos Mavridis; Andreas Scorilas; Diamantis C Sideris
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-27       Impact factor: 4.553

5.  Mechanism and Function of Angiogenin in Prostate Cancer.

Authors:  Nil Vanli; H U Guo-Fu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-24

6.  Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.

Authors:  Nil Vanli; Jinghao Sheng; Shuping Li; Zhengping Xu; Guo-Fu Hu
Journal:  Commun Biol       Date:  2022-06-25

7.  Angiogenin and plexin-B2 axis promotes glioblastoma progression by enhancing invasion, vascular association, proliferation and survival.

Authors:  Hailing Yang; Liang Yuan; Soichiro Ibaragi; Shuping Li; Robert Shapiro; Nil Vanli; Kevin A Goncalves; Wenhao Yu; Hiroko Kishikawa; Yuxiang Jiang; Alexander J Hu; Daniel Jay; Brent Cochran; Eric C Holland; Guo-Fu Hu
Journal:  Br J Cancer       Date:  2022-04-13       Impact factor: 9.075

Review 8.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

9.  Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.

Authors:  Wenhao Yu; Kevin A Goncalves; Shuping Li; Hiroko Kishikawa; Guangjie Sun; Hailing Yang; Nil Vanli; Yunxia Wu; Yuxiang Jiang; Miaofen G Hu; Roland H Friedel; Guo-Fu Hu
Journal:  Cell       Date:  2017-11-02       Impact factor: 41.582

10.  Angiogenin negatively regulates the expression of basic fibroblast growth factor (bFGF) and inhibits bFGF promoter activity.

Authors:  Jia Zhao; Dezhong Wen; Wenhua Jiang; Jinna Song; Jianli Yang; Xiang Gao; Hui Xue; Li Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.